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The aging of populations around the world has been associated with increases in 
morbidity and mortality attributable to lung diseases. Advancing age increases the 
susceptibility to severe bacterial pneumonia. The annual incidence of community-acquired 
pneumonia (CAP) in the United States has recently been estimated as 248 cases per 10,000 
adults, and the incidence of hospitalization for pneumonia was approximately 25 times higher 
among adults ≥80 years old than among adults 18–49 years old.(Jain, et al., 2015)CAP 
hospitalizations cost $13 billion USD annually, and this figure is expected to grow with the 
aging population.(Brown, et al., 2018) Japan has been the most rapidly aging society in the 
world, with a life expectancy of 80.1 years for men and 86.4 years for women. (Tokudome, 
et al., 2016)Pneumonia is the third highest cause of death, with most of these deaths 
occurring among seniors.(Ishiguro, et al., 2016) 
 
Besides the high mortality, senior CAP patients also experience deteriorations of 
functional status during and after treatment, as an important component of quality of life for 
older adults and their caregivers.(Simone & Haas, 2013) The prevalence of functional 
declines has been reported at 8.6% among CAP patients. (Kosai, et al., 2014)Functional 
declines during or after hospitalization are associated with adverse health outcomes, 
prolonged hospital stays, more frequent episodes of early hospital readmission and even 
higher long-term mortality rates.(Jeon, et al., 2017; Tonkikh, et al., 2016) Only a few studies 
have focused on changes in functional status for seniors after hospitalization. The present 
study focused on changes of functional status delaying discharge for CAP in seniors. 
 
2. Materials and method  
Senior patients hospitalized with CAP were divided into two groups: early discharge 
group, discharged ≤1 week after the end of antibiotic treatment; and a delayed discharge 
group, discharged >1 week after the end of antibiotic treatment. All enrolled cases had been 
diagnosed with CAP according to definitions in the American Thoracic Society/Infectious 
Diseases Society of America guideline. 
 
Patients who fulfilled all the following inclusion criteria were enrolled in the study: 1) age 
>64 years; 2) symptoms compatible with pneumonia (eg, fever, cough, sputum, pleuritic 
chest pain, or dyspnea); and 3) appearance of new pulmonary infiltrates consistent with 
pneumonia  
on chest X-ray or computed tomography. Duration of antibiotic treatment was determined 
including both injections and oral anti-bacterial medicines. Functional status was assessed 
on admission and at discharge. Requirements for rehabilitation were determined on the day 
of admission. 
 
Cases of healthcare-associated pneumonia (HCAP) and hospital-acquired pneumonia 
(HAP) were excluded. Repeated episodes of pneumonia in the same patient within a 2-week 
period were regarded as a single episode. Cases with complications that occurred during 
admission (myocardial infarction, femoral fracture, cerebral infarction, etc.) and that would 
have affected discharge from hospital were also excluded. 
 
3. Result 
We identified 1368 patients diagnosed with pneumonia. After excluding 1043 cases with 
reasons, the remaining 325 cases were included in the study, comprising 170 patients in the 
early group and 155 patients in the delayed group. Participants comprised 212 men (65.2%) 
and 113 women (34.8%), with a median age of 80 years. Patients in the delayed group were 
older and showed higher ratios of dementia, aspiration and higher PSI category. First-choice 
antibiotics showed no significant difference between groups (p=0.83). 
 
Multivariable analyses of factors contributing to delayed discharge and in-hospital 
mortality are conducted. Decreased PS, enrolment for rehabilitation, PSI category, aspiration 
and age were independently associated with delayed discharge (odds ratio (OR) 4.31, 95% 
confidence interval (CI) 2.32–7.98; 2.34, 95% CI 1.43–3.82; 3.63, 95% CI 1.37–9.69 (PSI III 
vs II); 5.08, 95% CI 1.81–14.3 (PSI IV vs II), 15.96, 95% CI 4.56–55.8 (PSI V vs II); 2.48, 
95% CI 1.11–5.98; and 1.03, 95% CI 1.01–1.06; respectively). Decreased PS, PSI V, 
aspiration and age were independently associated with in-hospital mortality (OR 21.6, 95% 
CI 5.1–119.1; 18.3, 95% CI 3.8–93.2; 4.61, 95% CI 1.35–16.22 and 1.04, 95% CI 1.01–1.09; 
respectively). 
 
4. Discussion  
In this retrospective cohort study, decreased functional status was observed more 
frequently in the delayed discharge group than in the early discharge group. After 
multivariable regression analysis, decreased functional status was identified as an 
independent factor contributing to delayed discharge. Only a few patients in the delayed 
group could be discharged within 2 weeks, and more than half could not be discharged within 
4 weeks. Decreased functional status was considered to affect length of stay in both the short 
and long term after admission. In the delayed group, despite a higher frequency of enrolment 
to receive rehabilitation, declines in functional status were also more frequent. Exercise or 
sports in midlife reduces the risk of functional limitations and disability, but effective methods 
of rehabilitation to prevent declines in functional status remain unclear for seniors. A need 
for rehabilitation itself was found to prolong the length of stay.  
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